최신 시험

EudraCT Number: 2004-001901-81

Sponsor Protocol Number: AISAR-01-04

Start Date: 2004-07-23

Sponsor Name: AISAR ASSOCIAZIONE ITALIANA PER LO STUDIO DEGLI ANTIMICROBICI E DELLE RESISTENZE

Full Title: Efficacy and tollerability of thiamphenicol glycinate acetylcysteinate, given in sequential therapy sistematic and aerosol or by aerosol in the treatment of hight respiratory tract acute infectio...

Medical condition: terapia sequenziale sistemica ed aerosol delle infezioni acute e/o subacute/ricorrenti delle alte vie respiratorie

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10004018		HLGT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2004-000772-14

Sponsor Protocol Number: TKT027

Start Date: 2004-07-23

Sponsor Name: TKT Inc

Full Title: A Phase I-II Pharmacokinetic/Pharmacodynamic Study of Replagal to Assess the Effects of Alternative Dose and Regimen in Patients with Fabry Disease (TKT027)

Medical condition: Fabry Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10016016		PT

Population Age: Adults

Gender: Male

Trial protocol: CZ (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000830-35

Sponsor Protocol Number: RIS-SCH-3007

Start Date: 2004-07-23

Sponsor Name: JANSSEN-CILAG

Full Title: Maintenance of the clinical response with long-acting injectable Risperidone in patients with Schizophrenia or schizoaffective disorders

Medical condition: Schizophrenia or schizoaffective disorder

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10039621		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-001362-40

Sponsor Protocol Number: CSTI571BIT15

Start Date: 2004-07-22

Sponsor Name: NOVARTIS FARMA

Full Title: PHASE II STUDY OF IMATINIB MESYLATE IN CHORDOMA

Medical condition: Treatment of advanced or unresectable chordoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10008747		PT

Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-000311-26

Sponsor Protocol Number: 0431-019

Start Date: 2004-07-21

Sponsor Name: Merck & Co., Inc.

Full Title: A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 to Patients with Type 2 Diabetes Mellitus who Have Inadequate Glycemic Control on Piogli...

Medical condition: Type 2 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10045242		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) AT (Completed) IT (Completed) DK (Completed)

Trial results: View results

EudraCT Number: 2004-000313-19

Sponsor Protocol Number: 0431-021

Start Date: 2004-07-21

Sponsor Name: Merck & Co., Inc.

Full Title: A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of MK-0431 Monotherapy in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control

Medical condition: Type 2 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10045242		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2004-000625-30

Sponsor Protocol Number: INOT22

Start Date: 2004-07-21

Sponsor Name: INO Therapeutics

Full Title: Comparison of Supplemental Oxygen and Nitric Oxide for Inhalation Plus Oxygen in the Evaluation of the Reactivity of the Pulmonary Vasculature During Acute Pulmonary Vasodilator Testing

Medical condition: : Nitric Oxide for inhalation at 800ppm, plus 100% O2, to be used to assess pulmonary vaso reactivity during Pulmonary Vasodilator Testing

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: ES (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2004-002302-30

Sponsor Protocol Number: 83/2004/U/Sper

Start Date: 2004-07-20

Sponsor Name: AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

Full Title: FMZ Fludarabine, Mitoxantrone, Zevalin regimen a phase II study as front-line treatment in indolent non-follicular non-Hodgkins lymphoma patients

Medical condition: Confirmed histologic diagnosis according to the REAL classification of B-cell indolent lymphoma including small lymphocytic, immunocytoma, and marginal zone lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10003900		HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000614-39

Sponsor Protocol Number: 288-00

Start Date: 2004-07-20

Sponsor Name: MERCK SHARP DOHME

Full Title: A multicenter, randomized, double blind study comparing the clinical effects of intravenous montelukast with palcebo in patients with acute asthma

Medical condition: ACUTE ASTHMA

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10038738		SOC

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed) DK (Completed)

Trial results: View results

EudraCT Number: 2004-002273-24

Sponsor Protocol Number: 81/2004/U

Start Date: 2004-07-20

Sponsor Name: AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

Full Title: A phase 2 trial of CHOP chemotherapy followed by Zevalin for untreated elderly diffuse large b-cell lymphoma DLBCL patients

Medical condition: Confirmed histologic diagnosis according to the REAL classification of diffuse large B-cell lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10012818		PT

Population Age: Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

최신 시험

스폰서 및 공동 작업자

건강 상태

약물 개입